Superworth

Myomo EPS MYO

Diluted earnings per share by quarter and over the last twelve months, from 2016.

Last 12 months, to Jun 30, 2026
−$0.34
Latest quarter, Q2 FY26
−$0.09
Fiscal year 2025
−$0.37

Myomo's earnings per share was −$0.34 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.09.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.37n/a
FY2024−$0.17n/a
FY2023−$0.28n/a
FY2022−$1.52n/a
FY2021−$1.89n/a
FY2020−$4.70n/a
FY2019−$21.00n/a
FY2018−$25.20n/a
FY2017−$160.80n/a
FY2016−$123.30n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.09n/a−$0.34
Q1 FY26−$0.07n/a−$0.36
Q4 FY25−$0.09n/a−$0.37
Q3 FY25−$0.09n/a−$0.29
Q2 FY25−$0.11n/a−$0.23
Q1 FY25−$0.08n/a−$0.15
Q4 FY24−$0.01n/a−$0.17
Q3 FY24−$0.03n/a−$0.23
Q2 FY24−$0.03n/a−$0.26
Q1 FY24−$0.10n/a−$0.27
Q4 FY23−$0.07n/a−$0.28
Q3 FY23−$0.06n/a−$0.50

Against its peers

Companies in Medical - Instruments & Supplies nearest Myomo's size, closest first, today.

CompanyEPS, 12 monthsGrowth
MYOMyomo−$0.34
APTAlpha Pro Tech$0.41+24% a year
NEPHNephros$0.16+33% a year
KEQUKewaunee Scientific$2.76−33% a year
PDEXPro DEX$4.11+52% a year
UTMDUtah Medical Products$3.28−12% a year
INFUInfuSystem$0.41+78% a year
EMBCEmbecta$1.47+3% a year
Peer median$1.47

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Myomo

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.